Inherited heart diseases, also known as genetic or familial cardiovascular conditions, are a group of disorders that are passed down from one generation to another through genetic mutations. These conditions affect the structure and function of the heart, potentially leading to serious cardiac complications. Common examples of inherited heart diseases include hypertrophic cardiomyopathy, arrhythmogenic right ventricular dysplasia, and familial hypercholesterolemia. Unlike acquired heart conditions, which develop over time due to lifestyle factors or environmental influences, inherited heart diseases are predetermined by the genetic makeup of an individual. Early detection and management are crucial in mitigating the impact of these conditions, as they can often remain asymptomatic until later stages. Genetic testing and counseling play pivotal roles in identifying individuals at risk and guiding appropriate interventions. Understanding the genetic basis of inherited heart diseases not only aids in personalized treatment plans but also facilitates efforts to prevent their transmission to future generations. As researchers continue to delve into the intricate genetic underpinnings of cardiovascular disorders, advancements in diagnostics and therapies offer hope for improved outcomes and a better quality of life for individuals affected by these inheritable conditions.
Title : Pharmacological advancement in pulmonary arterial hypertension treatment - Contribution of treprostinil dry-powder formulation
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Personalized and Precision Medicine (PPM) and PPN-guided cardiology practice as a unique model via translational applications and upgraded business modeling to secure human healthcare, wellness and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibodies with functionality as a new generation of translational tools designed to monitor autoimmune myocarditis at clinical and subclinical stages
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation